HealthEquity, Inc. (NASDAQ:HQY) was downgraded by equities researchers at BidaskClub from a “hold” rating to a “sell” rating in a research note issued on Wednesday.

Several other equities research analysts have also weighed in on HQY. Zacks Investment Research raised HealthEquity from a “hold” rating to a “buy” rating and set a $58.00 price objective for the company in a report on Wednesday, October 11th. TheStreet raised HealthEquity from a “c” rating to a “b” rating in a report on Monday, July 31st. Robert W. Baird reissued a “hold” rating on shares of HealthEquity in a report on Thursday, September 21st. Oppenheimer Holdings, Inc. reissued a “buy” rating and issued a $61.00 price objective on shares of HealthEquity in a report on Wednesday, September 6th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $56.00 price objective on shares of HealthEquity in a report on Tuesday, September 5th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $57.17.

Shares of HealthEquity (NASDAQ HQY) traded up 0.60% during midday trading on Wednesday, hitting $50.13. 279,290 shares of the stock were exchanged. The firm has a market capitalization of $3.03 billion, a price-to-earnings ratio of 74.38 and a beta of 1.80. The stock’s 50-day moving average price is $47.93 and its 200-day moving average price is $47.08. HealthEquity has a 1-year low of $30.34 and a 1-year high of $54.95.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.13. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The company had revenue of $56.90 million during the quarter, compared to analyst estimates of $55.66 million. During the same quarter last year, the firm posted $0.16 EPS. The firm’s revenue for the quarter was up 28.7% on a year-over-year basis. On average, analysts forecast that HealthEquity will post $0.71 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/10/18/healthequity-inc-hqy-cut-to-sell-at-bidaskclub.html.

In other HealthEquity news, major shareholder Berkley Capital, Llc sold 29,032 shares of HealthEquity stock in a transaction dated Friday, October 6th. The stock was sold at an average price of $51.97, for a total transaction of $1,508,793.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Darcy G. Mott sold 9,500 shares of HealthEquity stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $42.00, for a total value of $399,000.00. Following the sale, the vice president now owns 84,500 shares of the company’s stock, valued at approximately $3,549,000. The disclosure for this sale can be found here. Insiders have sold a total of 715,683 shares of company stock valued at $36,594,008 in the last ninety days. Insiders own 19.00% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the company. Wasatch Advisors Inc. boosted its position in shares of HealthEquity by 2.2% during the 2nd quarter. Wasatch Advisors Inc. now owns 2,442,180 shares of the company’s stock valued at $121,694,000 after acquiring an additional 52,885 shares during the last quarter. Public Employees Retirement System of Ohio boosted its position in shares of HealthEquity by 5.7% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 113,534 shares of the company’s stock valued at $5,657,000 after acquiring an additional 6,095 shares during the last quarter. Amussen Hunsaker & Associates LLC bought a new stake in shares of HealthEquity during the 2nd quarter valued at about $11,598,000. 1st Global Advisors Inc. bought a new stake in shares of HealthEquity during the 2nd quarter valued at about $213,000. Finally, Piedmont Investment Advisors LLC bought a new stake in shares of HealthEquity during the 2nd quarter valued at about $478,000. Hedge funds and other institutional investors own 90.97% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.